Hepatocyte growth factor secretion by cancer associated fibroblast (CAFs) can also activate receptor tyrosine kinases (RTKs) and the MAPK and PI3K/AKT pathways driving drug resistance [75]. The gene discussed is AKT1; the disease is cancer.